J. Permuth-wey and T. Sellers, Epidemiology of Ovarian Cancer, Methods Mol Biol, vol.472, pp.413-437, 2009.
DOI : 10.1007/978-1-60327-492-0_20

A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu et al., Cancer Statistics, 2008, Cancer statistics, pp.71-96, 2008.
DOI : 10.3322/CA.2007.0010

Y. Shimizu, S. Kamoi, S. Amada, F. Akiyama, and S. Silverberg, Toward the development of a universal grading system for ovarian epithelial carcinoma, Cancer, vol.32, issue.5, pp.893-901, 1998.
DOI : 10.1002/(SICI)1097-0142(19980301)82:5<893::AID-CNCR14>3.0.CO;2-W

M. Shih-ie and R. Kurman, Ovarian Tumorigenesis, The American Journal of Pathology, vol.164, issue.5, pp.1511-1518, 2004.
DOI : 10.1016/S0002-9440(10)63708-X

K. Zorn, T. Bonome, L. Gangi, G. Chandramouli, C. Awtrey et al., Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer, Clinical Cancer Research, vol.11, issue.18, pp.116422-6430, 2005.
DOI : 10.1158/1078-0432.CCR-05-0508

M. Kobel, S. Kalloger, N. Boyd, S. Mckinney, E. Mehl et al., Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies, PLoS Medicine, vol.123, issue.12, p.232, 2008.
DOI : 10.1371/journal.pmed.0050232.st004

H. Song, S. Ramus, J. Tyrer, K. Bolton, A. Gentry-maharaj et al., A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2, Nature Genetics, vol.447, issue.9, pp.41996-1000, 2009.
DOI : 10.1093/hmg/ddp078

D. Schwartz, S. Kardia, K. Shedden, R. Kuick, G. Michailidis et al., Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas, Cancer Res, issue.16, pp.624722-4729, 2002.

N. White, M. Mathews, G. Yousef, A. Prizada, C. Popadiuk et al., KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma, British Journal of Cancer, vol.26, issue.7, pp.1107-1113, 2009.
DOI : 10.1158/1078-0432.CCR-07-1409

F. Barbieri, A. Bajetto, and T. Florio, Role of Chemokine Network in the Development and Progression of Ovarian Cancer: A Potential Novel Pharmacological Target, Journal of Oncology, vol.71, issue.2, p.426956, 2010.
DOI : 10.1016/j.jnutbio.2006.08.006

G. Lazennec and R. A. , Chemokines and chemokine receptors: new insights into cancer-related inflammation, Trends in Molecular Medicine, vol.16, issue.3, pp.133-144, 2010.
DOI : 10.1016/j.molmed.2010.01.003

J. Wilson and F. Balkwill, The role of cytokines in the epithelial cancer microenvironment, Seminars in Cancer Biology, vol.12, issue.2, pp.113-120, 2002.
DOI : 10.1006/scbi.2001.0419

I. Kryczek, S. Wei, E. Keller, R. Liu, and W. Zou, Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis, AJP: Cell Physiology, vol.292, issue.3, pp.987-95, 2007.
DOI : 10.1152/ajpcell.00406.2006

W. Zou, V. Machelon, A. Coulomb-l-'hermine, J. Borvak, F. Nome et al., Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells, Nature Medicine, vol.7, issue.12, pp.1339-1346, 2001.
DOI : 10.1038/nm1201-1339

C. Scotton, J. Wilson, K. Scott, G. Stamp, G. Wilbanks et al., Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer, Cancer Res, issue.20, pp.625930-5938, 2002.

I. Kryczek, A. Lange, P. Mottram, X. Alvarez, P. Cheng et al., CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers, Cancer Res, vol.65, issue.2, pp.465-472, 2005.

C. Scotton, J. Wilson, D. Milliken, G. Stamp, and F. Balkwill, Epithelial cancer cell migration: a role for chemokine receptors?, Cancer Res, issue.13, pp.614961-4965, 2001.

H. Kajiyama, K. Shibata, M. Terauchi, K. Ino, A. Nawa et al., Involvement of SDF-1??/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma, International Journal of Cancer, vol.276, issue.1, pp.91-99, 2008.
DOI : 10.1002/ijc.23083

M. Barbolina, M. Kim, Y. Liu, J. Shepard, A. Belmadani et al., Microenvironmental Regulation of Chemokine (C-X-C-Motif) Receptor 4 in Ovarian Carcinoma, Molecular Cancer Research, vol.8, issue.5, pp.653-664, 2010.
DOI : 10.1158/1541-7786.MCR-09-0463

D. Pils, A. Pinter, J. Reibenwein, A. Alfanz, P. Horak et al., In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway, British Journal of Cancer, vol.5, issue.3, pp.96485-491, 2007.
DOI : 10.1006/gyno.1995.1099

Y. Jiang, X. Wu, B. Shi, W. Wu, and G. Yin, Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: An independent prognostic factor for tumor progression, Gynecologic Oncology, vol.103, issue.1, pp.226-233, 2006.
DOI : 10.1016/j.ygyno.2006.02.036

N. Auersperg, A. Wong, K. Choi, S. Kang, and P. Leung, Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology, Endocrine Reviews, vol.22, issue.2, pp.255-288, 2001.
DOI : 10.1210/er.22.2.255

A. Karst and R. Drapkin, Ovarian Cancer Pathogenesis: A Model in Evolution, Journal of Oncology, vol.42, issue.8-9, p.932371, 2010.
DOI : 10.1038/nrc2618

S. Camilleri-broet, A. Hardy-bessard, L. Tourneau, A. Paraiso, D. Levrel et al., HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group, Annals of Oncology, vol.15, issue.1, pp.104-112, 2004.
DOI : 10.1093/annonc/mdh021

M. Tuefferd, J. Couturier, F. Penault-llorca, A. Vincent-salomon, P. Broet et al., HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients, PLoS ONE, vol.144, issue.11, pp.2-1138, 2007.
DOI : 10.1371/journal.pone.0001138.t003

A. Bois, J. Herrstedt, A. Hardy-bessard, H. Muller, P. Harter et al., Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer, Journal of Clinical Oncology, vol.28, issue.27, pp.4162-4169, 2010.
DOI : 10.1200/JCO.2009.27.4696

R. Drapkin, C. Crum, and J. Hecht, Expression of candidate tumor markers in ovarian carcinoma and benign ovary: Evidence for a link between epithelial phenotype and neoplasia, Human Pathology, vol.35, issue.8, pp.1014-1021, 2004.
DOI : 10.1016/j.humpath.2004.04.014

N. Redjimi, F. Gaudin, C. Touboul, D. Emilie, M. Pallardy et al., Identification of glucocorticoid-induced leucine zipper as a key regulator of tumor cell proliferation in epithelial ovarian cancer, Molecular Cancer, vol.8, issue.1, p.83, 2009.
DOI : 10.1186/1476-4598-8-83
URL : https://hal.archives-ouvertes.fr/inserm-00663931

. Machelon, 11:97 http://www.biomedcentral.com/1471-2407/11/97 expression of SDF-1 by mesothelial cells and biliary ductal plate epithelial cells, BMC Cancer Proc Natl Acad Sci, issue.15, pp.968585-8590, 1999.

K. Balabanian, J. Couderc, L. Bouchet-delbos, A. A. Berrebi, D. Foussat et al., Role of the Chemokine Stromal Cell-Derived Factor 1 in Autoantibody Production and Nephritis in Murine Lupus, The Journal of Immunology, vol.170, issue.6, pp.3392-3400, 2003.
DOI : 10.4049/jimmunol.170.6.3392
URL : https://hal.archives-ouvertes.fr/pasteur-00166866

I. Kryczek, N. Frydman, F. Gaudin, R. Krzysiek, R. Fanchin et al., The Chemokine SDF-1/CXCL12 Contributes to T Lymphocyte Recruitment in Human Pre-ovulatory Follicles and Coordinates with Lymphocytes to Increase Granulosa Cell Survival and Embryo Quality, American Journal of Reproductive Immunology, vol.202, issue.5, pp.270-283, 2005.
DOI : 10.1095/biolreprod.102.012211

A. Orimo, P. Gupta, D. Sgroi, F. Arenzana-seisdedos, T. Delaunay et al., Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion, Cell, vol.121, issue.3, pp.335-348, 2005.
DOI : 10.1016/j.cell.2005.02.034

K. Levanon, V. Ng, H. Piao, Y. Zhang, M. Chang et al., Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis, Oncogene, vol.60, issue.8, pp.291103-1113, 2010.
DOI : 10.1038/nature07955

H. Naora and D. Montell, Ovarian Cancer Metastasis: Integrating insights from disparate model organisms, Nature Reviews Cancer, vol.128, issue.5, pp.355-366, 2005.
DOI : 10.1016/j.devcel.2004.05.020

M. Wendt, P. Johanesen, N. Kang-decker, D. Binion, V. Shah et al., Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis, Oncogene, vol.393, issue.36, pp.254986-4997, 2006.
DOI : 10.1038/sj.onc.1209505

W. Zhou, Z. Jiang, N. Liu, F. Xu, P. Wen et al., Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas, Journal of Cancer Research and Clinical Oncology, vol.119, issue.1, pp.91-102, 2009.
DOI : 10.1007/s00432-008-0435-x

Y. Akishima-fukasawa, Y. Nakanishi, Y. Ino, Y. Moriya, Y. Kanai et al., Prognostic Significance of CXCL12 Expression in Patients With Colorectal Carcinoma, American Journal of Clinical Pathology, vol.132, issue.2, pp.202-210, 2009.
DOI : 10.1309/AJCPK35VZJEWCUTL

J. Liang, S. Zhu, R. Bruggeman, R. Zaino, D. Evans et al., High levels of expression of human stromal cellderived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma, Cancer Epidemiol Biomarkers Prev, issue.10, pp.192598-2604, 2010.

S. Hassan, C. Ferrario, U. Saragovi, L. Quenneville, L. Gaboury et al., The Influence of Tumor-Host Interactions in the Stromal Cell-Derived Factor-1/CXCR4 Ligand/Receptor Axis in Determining Metastatic Risk in Breast Cancer, The American Journal of Pathology, vol.175, issue.1, pp.66-73, 2009.
DOI : 10.2353/ajpath.2009.080948

K. Sasaki, S. Natsugoe, S. Ishigami, M. Matsumoto, H. Okumura et al., Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma, Oncology Reports, vol.21, issue.1, pp.65-71, 2009.
DOI : 10.3892/or_00000190

S. Gelmini, M. Mangoni, F. Castiglione, C. Beltrami, A. Pieralli et al., The CXCR4/CXCL12 axis in endometrial cancer, Clinical & Experimental Metastasis, vol.62, issue.3, pp.261-268, 2009.
DOI : 10.1007/s10585-009-9240-4

D. Gilbert, I. Chandler, A. Mcintyre, N. Goddard, R. Gabe et al., Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents, The Journal of Pathology, vol.14, issue.1, pp.94-102, 2009.
DOI : 10.1002/path.2436

S. Barbero, R. Bonavia, A. Bajetto, C. Porcile, P. Pirani et al., Stromal cell-derived factor 1 alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt, Cancer Res, issue.8, pp.631969-1974, 2003.

R. Lis, C. Touboul, P. Mirshahi, F. Ali, S. Mathew et al., Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12, International Journal of Cancer, vol.2010, issue.3, pp.715-725, 2010.
DOI : 10.1002/ijc.25619

C. Laguri, F. Arenzana-seisdedos, and H. Lortat-jacob, Relationships between glycosaminoglycan and receptor binding sites in chemokines???the CXCL12 example, Carbohydrate Research, vol.343, issue.12, pp.2018-2023, 2008.
DOI : 10.1016/j.carres.2008.01.047
URL : https://hal.archives-ouvertes.fr/hal-00274461

K. Balabanian, B. Lagane, S. Infantino, K. Chow, J. Harriague et al., The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes, Journal of Biological Chemistry, vol.280, issue.42, pp.28035760-35766, 2005.
DOI : 10.1074/jbc.M508234200

M. Thelen and S. Thelen, CXCR7, CXCR4 and CXCL12: An eccentric trio?, Journal of Neuroimmunology, vol.198, issue.1-2, pp.9-13, 2008.
DOI : 10.1016/j.jneuroim.2008.04.020

J. Burns, B. Summers, Y. Wang, A. Melikian, R. Berahovich et al., A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development, The Journal of Experimental Medicine, vol.62, issue.9, pp.2201-2213, 2006.
DOI : 10.1084/jem.188.10.1917

V. Mirisola, A. Zuccarino, B. Bachmeier, M. Sormani, J. Falter et al., CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival, European Journal of Cancer, vol.45, issue.14, pp.452579-2587, 2009.
DOI : 10.1016/j.ejca.2009.06.026